Anne-Birgitte Jacobsen

  • Consultant MD
  • +47 22 93 47 53
 

Publications 2019

Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
Dis Esophagus, 32 (2)
DOI 10.1093/dote/doy069, PubMed 30084992

von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
Dis Esophagus, 32 (2)
DOI 10.1093/dote/doy078, PubMed 30137281

Publications 2017

Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
Improved treatment decisions in patients with esophageal cancer
Acta Oncol, 56 (10), 1286-1294
DOI 10.1080/0284186X.2017.1346379, PubMed 28686501

Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
DOI 10.1007/s00405-017-4764-8, PubMed 29019001

Publications 2016

Klevebro F, Alexandersson von Döbeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016)
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
Ann Oncol, 27 (4), 660-7
DOI 10.1093/annonc/mdw010, PubMed 26782957

Publications 2015

Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015)
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
Eur J Surg Oncol, 41 (7), 920-6
DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010

Publications 2013

Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K (2013)
Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
Radiother Oncol, 107 (3), 428-33
DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761

Publications 2012

Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
Acta Oncol, 52 (4), 679-90
DOI 10.3109/0284186X.2012.731521, PubMed 23190360

Publications 2011

Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
Palliative interventions and prognosis in patients with advanced esophageal cancer
Dis Esophagus, 24 (7), 502-9
DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923

Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
Acta Oncol, 50 (7), 1068-74
DOI 10.3109/0284186X.2011.585998, PubMed 21745131

Publications 2010

Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Karlsen KO, Sandstad B, Bjordal K (2010)
Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital
Acta Oncol, 49 (2), 209-18
DOI 10.3109/02841860903246573, PubMed 19929566

Publications 2009

Gunnes N, Seierstad TG, Aamdal S, Brunsvig PF, Jacobsen AB, Sundstrøm S, Aalen OO (2009)
Assessing quality of life in a randomized clinical trial: correcting for missing data
BMC Med Res Methodol, 9, 28
DOI 10.1186/1471-2288-9-28, PubMed 19405936

Publications 2007

Fjøsne HE, Jacobsen AB, Lundgren S, Norwegian Breast Cancer Group (NBCG) (2007)
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up
Eur J Surg Oncol, 34 (1), 6-12
DOI 10.1016/j.ejso.2007.07.002, PubMed 17881183

Oldervoll LM, Loge JH, Kaasa S, Lydersen S, Hjermstad MJ, Thorsen L, Holte H, Jacobsen AB, Fosså SD (2007)
Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study
BMC Cancer, 7, 210
DOI 10.1186/1471-2407-7-210, PubMed 17997822

Page visits: 528